Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.
Moghrabi A, Friedman HS, Ashley DM, Bottom KS, Kerby T, Stewart E, Bruggers C, Provenzale JM, Champagne M, Hershon L, Watral M, Ryan J, Rasheed K, Lovell S, Korones D, Fuchs H, George T, McLendon RE, Friedman AH, Buckley E, Longee DC.
Moghrabi A, et al.
Neurosurg Focus. 1998 Apr 15;4(4):e3. doi: 10.3171/foc.1998.4.4.6.
Neurosurg Focus. 1998.
PMID: 17168503